… Chitosan has the potential to alleviate diabetic hyperglycemia by reducing hepatic
gluconeogenesis … effect of chitosan oligosaccharide (COS). COS supplementation has the …

… Chitosan oligosaccharide (COS) is an oligomer of chitosan prepared by the deacetylation of
… the beneficial effects of COS on obesity, dyslipidemia, diabetes mellitus, hyperglycemia, and …

… diabetes (T2DM) and eventually diabetic nephropathy (DN). Chitosan oligosaccharide (COS)
is an oligomer of chitosan … lipid lowering, anti-inflammation, anti-diabetes, and anti-oxidant …

Chitosan oligosaccharides (COS), hydrolysed products of chitosan, are low-molecular
weight polymers with a positive charge and good biocompatibility. COS have recently been …

… conditions, making them potential therapeutic substances for … oligosaccharide and deep-sea
water with fewer side effects An anti-obesity composition is presented, containing chitosan …

… Chitosan oligosaccharide (COS) provides potent anti-obesity … a potential prebiotic effect
improving gut dysbiosis and maintaining the intestinal epithelial barrier in obese and diabetic …

… high polymerization degree of chitosan oligosaccharide, a moderate … chitosan oligosaccharide
exhibited a higher inhibitory effect, indicating that the higher DP is related to stronger anti-…

… as an anti-obesity potential which can be further explored from marine sources. … chitosan
oligosaccharide were studied for their anti-obesity property in high-fat diet-induced obese …

… COS and chitosan are reported to have potential applications as prebiotics for their beneficial
influence on gut microbiota [22,23]. Here, we hypothesized that COS has a protective effect …

… The aim of this study was to investigate the effect of chitosan oligosaccharide (COS) on
NAFLD. Mice were fed either a control diet or a high-fat diet (HFD) with or without COS (200 or …